Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


MedCity morning read, Wednesday, April 8

7:57 am by | 0 Comments

Life Sciences Discovery Fund logoImagine if Ohio shut down its Third Frontier program? Or Indiana were to scuttle its 21st Century Fund?

The equivalent may happen in Washington, where Xconomy reports that the state will likely gut its 10-year, $350 million Life Science Discovery Fund. The fund usually gets about $65 million in the two-year allocation, but a Senate committee slashes that budget by 41 percent – down to $38 million. A House version leaves it just $5 million, using the rest to fill other holes in the state budget.

The state fund has delivered millions to researchers involved in vaccine research, cardiac care, drug delivery and other life-science technologies. “But it can’t claim to have discovered the next penicillin, and even in the best of times it would take years to show payoffs in new products, jobs, and regional prestige that such a program might be able to use to defend itself,” Xconomy notes.

Mental note to Midwest biotech recruiters: schedule trips to Washington.

Other stories worth a read:

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Chris Seper

By Chris Seper MedCity News

Chris Seper is the CEO at MedCity Media, which publishes MedCityNews.com. He is also a senior writer at MedCity News. Reach him at [email protected]
More posts by Author

0 comments